Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFR.L Regulatory News (AFR)

  • There is currently no data for AFR

Form 8.3 - AFREN PLC

6 Jan 2015 14:13

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose

AFREN PLC

relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 5 January 2015
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SEPLAT PETROLEUM DEVT CO PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 16,417,442 1.48% 9,828,614 0.89%
(2) Cash-settled derivatives:
7,349,624 0.66% 16,081,454 1.45%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 23,767,066 2.15% 25,910,068 2.34%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 47 0.4614 GBP
ORD Purchase 3,700 0.4344 GBP
ORD Purchase 22,667 0.4356 GBP
ORD Purchase 40,905 0.4321 GBP
ORD Purchase 43,359 0.4500 GBP
ORD Purchase 47,126 0.4326 GBP
ORD Purchase 56,107 0.4510 GBP
ORD Purchase 88,297 0.4371 GBP
ORD Purchase 91,710 0.4315 GBP
ORD Purchase 98,128 0.4427 GBP
ORD Purchase 99,995 0.4611 GBP
ORD Purchase 119,594 0.4340 GBP
ORD Purchase 239,815 0.4368 GBP
ORD Sale 925 0.4281 GBP
ORD Sale 5,047 0.4333 GBP
ORD Sale 10,000 0.4568 GBP
ORD Sale 22,081 0.4309 GBP
ORD Sale 32,065 0.4403 GBP
ORD Sale 46,771 0.4344 GBP
ORD Sale 60,435 0.4323 GBP
ORD Sale 82,295 0.4356 GBP
ORD Sale 86,057 0.4321 GBP
ORD Sale 100,434 0.4345 GBP
ORD Sale 152,290 0.4372 GBP
ORD Sale 236,079 0.4548 GBP
ORD Sale 267,380 0.4401 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
ORD CFD Long 4,647 0.4340 GBP
ORD CFD Long 4,796 0.4373 GBP
ORD SWAP Long 88,329 0.4400 GBP
ORD CFD Long 58,051 0.4303 GBP
ORD SWAP Long 352,126 0.4397 GBP
ORD SWAP Short 8,362 0.4315 GBP
ORD CFD Short 14,565 0.4252 GBP
ORD CFD Short 40,905 0.4321 GBP
ORD CFD Short 29,635 0.4500 GBP
ORD SWAP Short 217,020 0.4329 GBP
ORD CFD Short 239,815 0.4368 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 6 Jan 2015
Contact name: Jay Supaya
Telephone number: 0207 773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2015

Date   Source Headline
31st Jul 201510:39 amRNSCorporate update
27th Jul 20157:00 amRNSUpdate on General Meeting
21st Jul 20154:31 pmRNSUpdate on Upcoming General Meeting
15th Jul 20157:33 amRNSOperational and financial update
15th Jul 20157:30 amRNSSuspension - Afren PLC
8th Jul 20157:00 amRNSPublication of Supplementary Prospectus
1st Jul 20154:54 pmRNSDirector Declaration
25th Jun 20153:31 pmRNSResult of AGM
25th Jun 201511:00 amRNSAGM Statement
25th Jun 20157:00 amRNSBoard changes
22nd Jun 20157:00 amRNSLaunch of shareholder information microsite
19th Jun 20156:26 pmRNSProposed Debt Restructuring and Refinancing
12th Jun 20154:06 pmRNSExecutive Director Resignation / COO Appointment
10th Jun 20157:00 amRNSInterest payment due on 2020 Notes
29th May 20157:00 amRNSInterim Management Statement
29th May 20157:00 amRNSFinal Amount of the New Senior Notes
28th May 201510:58 amRNSNotification of Major Interest in Shares
18th May 20157:00 amRNSResignation of Non-Executive Directors
11th May 20157:00 amRNSInterest payment due on 2019 Notes
30th Apr 20154:37 pmRNSAnnual Financial Report
30th Apr 20154:34 pmRNSCompletion of interim funding
30th Apr 20154:31 pmRNS2014 Full Year Results
9th Apr 20157:00 amRNSInterest payment due on 2019 Notes
8th Apr 201510:34 amRNSResponse to AMNI's allegations regarding Okoro
7th Apr 201511:40 amRNSResponse to reports regarding CEO
1st Apr 20152:08 pmRNSUpdate on interim funding
30th Mar 20154:35 pmRNSPrice Monitoring Extension
23rd Mar 20157:00 amRNSUpdate on discussions with bondholders
20th Mar 20154:40 pmRNSSecond Price Monitoring Extn
20th Mar 20154:35 pmRNSPrice Monitoring Extension
16th Mar 20154:40 pmRNSSecond Price Monitoring Extn
16th Mar 20154:35 pmRNSPrice Monitoring Extension
13th Mar 20157:00 amRNSTrading statement and operations update
4th Mar 20157:00 amRNSUpdate on the Review of Afren's Capital Structure
2nd Mar 20157:00 amRNSUpdate on the Review of Afren's Capital Structure
17th Feb 20152:27 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
17th Feb 20152:22 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
16th Feb 20155:44 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
16th Feb 201511:30 amRNSForm 8.5 (EPT/RI)
16th Feb 201511:07 amRNSForm 8.5 (EPT/RI) - Afren Plc
16th Feb 201511:06 amRNSForm 8.5 (EPT/RI) - Afren Plc
16th Feb 201511:01 amPRNForm 8.3 - Afren Plc
16th Feb 201510:46 amRNSForm 8.5 (EPT/RI)
13th Feb 20154:35 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
13th Feb 20154:22 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
13th Feb 20154:01 pmRNSOffer Talks Terminated
13th Feb 20152:49 pmBUSForm 8.3 - AFREN PLC
13th Feb 20152:17 pmRNSForm 8.3 - [Afren PLC]
13th Feb 20151:56 pmRNSOffer Talks Terminated
13th Feb 20151:43 pmRNSForm 8.3 - Afren PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.